A first in Belgium: A mutuality involved in funding molecular diagnostic tests for cancer

Gosselies and La Louvière, Belgium. The Mutualité Libérale Namur-Hainaut announces funding for the OncoDNA Company’s genetic profiling test. This initiative is a first in Belgium and a major step towards precision médicine. Each adult member who has a stage 3 or 4 solid tumour cancer and relapses after first-line treatment will receive a partial reimbursement for their tumour analysis known as “OncoDEEP”, amounting to €1,500, or around half of its cost. Discover the official press release here.

Read more

Kangstem Biotech selects MaSTherCell for GMP manufacturing

Kangstem Biotech, a biotechnology company specializing in developing cell therapies using mesenchymal stem cells derived from human umbilical cord blood, today announces the selection of MaSTherCell as its contract manufacturing partner for its European clinical trial of FURESTEM-AD. Discover the official press release here.

Read more